Indole ring linked thiazolidone hybrid molecules as potent tubulin inhibitors

Tubulin inhibitors are a prominent class of antineoplastic agents for cancer therapy, with many established drugs originating from plant-derived compounds such as vinca alkaloids and taxanes. A new series of twenty-four 5-(substituted) benzylidene-2-{[2-(3H-indol-3-yl)ethyl]imino}-3-phenyl-1,3-thiazolidin-4-one derivatives (1−24) was synthesized based on assuming that it would inhibit tubulin polymerization, successfully. To assess their biological potential these derivatives were subjected to a comprehensive screening including cytotoxic activity using various cancer cell lines, cell death studies, cell motility and migration analysis, assessment of the compounds' ability to inhibit tubulin polymerization, and computational analysis. Out of the twenty-four synthesized compounds, specifically compounds 8, 10, 15, 21, and 23 demonstrated a desirable selective cytotoxic effect against the MCF7 cancer cell line compared to the healthy epithelial counterparts. Mechanistic studies confirmed that these five active compounds functioned as tubulin polymerization inhibitors, exhibiting an inhibitory mechanism similar to that of vinblastine. Computational analyses strongly supported these findings, demonstrating that the five active compounds possessed a high affinity binding to the tubulin structure. Compound 15 was identified as the most potent derivative, causing significant cell cycle arrest and inducing a distinct apoptotic effect in MCF7 cells. 2-{[2-(3H-indol-3-yl)ethyl]imino}-3-phenyl-5-[(3-hydroxy-4-methoxy phenyl)methylidene]-1,3-thiazolidin-4-one (15) represents a novel chemical series targeting microtubules. This compound emerged as a promising potential hit molecule due to its selective cytotoxicity against MCF7 cells, potent vinblastine-like tubulin polymerization inhibition. • Novel indole-thiazolidine hybrid molecules synthesized as anticancer agents. • The five compounds exerted antiproliferative action on MCF7 cells, selectively. • Compounds inhibitory actions on tubulin polymerization supported by computational analysis. • Tubulin polymerization was defected upon compound 15 treatment which caused apoptosis. • Compound 15 possessing 3-hydroxy-5-methoxy emerged as a potential hit molecule.

Authors

Institutions

Publication Details

Journal
Letters in Drug Design & Discovery
Published
2025-12-01
DOI
https://doi.org/10.1016/j.lddd.2026.100367
Primary Topic
Synthesis and biological activity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Indole ring linked thiazolidone hybrid molecules as potent tubulin inhibitors

Dilek Telci, Başak Aru, Burçin Güngör, Ahmet Can Timuçin et al.
Letters in Drug Design & Discovery
Synthesis and biological activity
article

Indole ring linked thiazolidone hybrid molecules as potent tubulin inhibitors

Dilek Telci, Başak Aru, Burçin Güngör, Ahmet Can Timuçin, İpek Bedir, Naz Ünal, Güneş Yıldırım Akdeniz, Zulal Sevgi Dede, Gülderen Yanıkkaya Demirel, Abdulrahman Abba, Hülya Akgün
article en

Abstract

Tubulin inhibitors are a prominent class of antineoplastic agents for cancer therapy, with many established drugs originating from plant-derived compounds such as vinca alkaloids and taxanes. A new series of twenty-four 5-(substituted) benzylidene-2-{[2-(3H-indol-3-yl)ethyl]imino}-3-phenyl-1,3-thiazolidin-4-one derivatives (1−24) was synthesized based on assuming that it would inhibit tubulin polymerization, successfully. To assess their biological potential these derivatives were subjected to a comprehensive screening including cytotoxic activity using various cancer cell lines, cell death studies, cell motility and migration analysis, assessment of the compounds' ability to inhibit tubulin polymerization, and computational analysis. Out of the twenty-four synthesized compounds, specifically compounds 8, 10, 15, 21, and 23 demonstrated a desirable selective cytotoxic effect against the MCF7 cancer cell line compared to the healthy epithelial counterparts. Mechanistic studies confirmed that these five active compounds functioned as tubulin polymerization inhibitors, exhibiting an inhibitory mechanism similar to that of vinblastine. Computational analyses strongly supported these findings, demonstrating that the five active compounds possessed a high affinity binding to the tubulin structure. Compound 15 was identified as the most potent derivative, causing significant cell cycle arrest and inducing a distinct apoptotic effect in MCF7 cells. 2-{[2-(3H-indol-3-yl)ethyl]imino}-3-phenyl-5-[(3-hydroxy-4-methoxy phenyl)methylidene]-1,3-thiazolidin-4-one (15) represents a novel chemical series targeting microtubules. This compound emerged as a promising potential hit molecule due to its selective cytotoxicity against MCF7 cells, potent vinblastine-like tubulin polymerization inhibition. • Novel indole-thiazolidine hybrid molecules synthesized as anticancer agents. • The five compounds exerted antiproliferative action on MCF7 cells, selectively. • Compounds inhibitory actions on tubulin polymerization supported by computational analysis. • Tubulin polymerization was defected upon compound 15 treatment which caused apoptosis. • Compound 15 possessing 3-hydroxy-5-methoxy emerged as a potential hit molecule.

Letters in Drug Design & DiscoveryVol. 22(12)
Yeditepe University (TR), Sabancı Üniversitesi (TR), Kent Hastanesi (TR)
Zero hunger
Openalex Percentile: Top 30%
Synthesis and biological activity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.